Lung Cancer Special Issue (2)

How one mother learned that “broken hearts still beat.”

New therapies offer options for patients with non-small cell lung cancer whose disease has spread to the brain.

Paraneoplastic syndromes are uncommon disorders that can arise with any cancer type but are more common with lung cancer.

New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer.

How a cancer diagnosis leaves one woman feeling humbled.

Disparities in lung cancer care must be closed to improve patient outcomes.

Results uncover a need to ensure understanding and give adequate information about genomics in risk of other disease, familial cancer.

An aptly named app brings community to patients and caregivers around the world.

Patients with RET-fusion-positive non-small cell lung cancer (NSCLC) had a high response to LOXO-292 (selpercatinib), according to findings from the largest clinical trial of patients with RET-altered cancers.

Three survivors describe what life looks like seven and 15 years out from diagnosis.

Cancer can trigger symptoms that seem as mysterious as their name: paraneoplastic syndromes.